An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
AVENTURA, Fla., Feb. 4, 2026 /PRNewswire/ — Nuvo Intl Group Inc. today announced that pregnant moms can lease the FDA-cleared INVU wearable solution , a cloud-based pregnancy monitoring platform designed for use at home or at work, directly through their physician or healthcare provider.
OKLAHOMA CITY, Feb. 4, 2026 /PRNewswire/ — Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter CGM.
For the first time, the new scope allowed physicists to observe terahertz “jiggles” in a superconducting fluid.
TSC Life announced that it received FDA clearance for its Fluido Compact fluid warming system for pediatric use.
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician.
A University of Missouri researcher has unveiled a safer, smarter way to fight drug-resistant infections.
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes.